CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Dec 1, 2025 · 10-K · 92 days after period end · 0001683168-25-008736
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $100.00K | — |
| Net Income | — | -$60.58K | -$573.55K | -$479.71K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Aug 31, 2025 · filed Dec 1, 2025 · 92 d after period end
